Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether NHS clinical pathways for patients prescribed weight loss medications require access to dietary and nutritional support, including referral to dietetic services.

Weight loss medicines were initially only available through National Health Service specialist weight management services. In specialist services, patients receive wraparound care from a multidisciplinary team providing nutritional, psychological, and medical support, tailored to individual need. Where clinically appropriate, this will include specialist dietetic services.

From June 2025, the obesity medicine tirzepatide, brand name Mounjaro, has been made available in primary care through a phased approach. In primary care, clinical oversight is provided by general practitioners and other prescribing healthcare professionals, with wraparound support delivered through locally commissioned services or via the national Healthier You: NHS Behavioural Support for Obesity Prescribing service. Dietary support typically forms part of the wider wraparound package of care.